YWHAB and breast carcinoma: High expression of YWHAB confers a survival disadvantage to breast cancer patients in both GEPIA with TCGA samples [logRank p = 0.0057, HR (high) =1.6, Fig. 3a] and KMPD with GEO samples [217718_s_at, logRank p = 8e-04, HR = 1.44(1.16–1.79), Fig. 3b].